Skip to content

Clinical trials

Completed Phase 2 Pathologic Processes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Phase: Phase 2 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20094
20101
20111
20161
20172
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
GlaxoSmithKline1
Géraldine Martens1
InSilico Medicine Hong Kong Limited1
InflaRx GmbH1
KAI Pharmaceuticals1
Neuroscience Trials Australia1
Simon Fraser University1
Uppsala University1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes12
Cardiovascular Diseases4
Fibrosis4
Heart Diseases3
Central Nervous System Diseases2
Cicatrix2
Digestive System Diseases2
Inflammation2
Lung Diseases2
Myocardial Infarction2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.